Combo immunotherapy may herald new standard of care for kidney cancer – EurekAlert (press release)
EurekAlert (press release) |
Combo immunotherapy may herald new standard of care for kidney cancer
EurekAlert (press release) DALLAS – July 05, 2017 – Combination therapy with two immunotherapy drugs produces an unprecedented doubling of response rates from 20 percent to 40 percent, a new study shows. The multicenter trial involving 100 patients showed that the addition of … |
